LGMN Matched Antibody Pair (689) (APMAB-689LY)

Ke, B. Y., Qin, Y. S., Cheng, L., & Wang, S. Z. (2023). Legumain: a potential biomarker for atherosclerosis. Journal of Pharmacy and Pharmacology, 75(11), 1395-1404.

Ehsan, M., Hu, R. S., Wang, M., Hou, J. L., Rashid, M., & Malik, M. I. (2023). Immune modulation of goat monocytes by Fasciola gigantica Legumain-1 protein (Fg-LGMN-1). Experimental Parasitology, 108671.

He, Y., Zou, P., Lu, J., Lu, Y., Yuan, S., Zheng, X., ... & Zhou, S. (2023). CD4+ T-Cell Legumain Deficiency Attenuates Hypertensive Damage via Preservation of TRAF6. Circulation Research.

Pan, L., Bai, P., Weng, X., Liu, J., Chen, Y., Chen, S., ... & Ge, J. (2022). Legumain is an endogenous modulator of integrin αvβ3 triggering vascular degeneration, dissection, and rupture. Circulation, 145(9), 659-674.

Liu, C., Wang, J., Zheng, Y., Zhu, Y., Zhou, Z., Liu, Z., ... & Chen, J. (2022). Autocrine pro-legumain promotes breast cancer metastasis via binding to integrin αvβ3. Oncogene, 41(34), 4091-4103.

Jia, D., Chen, S., Bai, P., Luo, C., Liu, J., Sun, A., & Ge, J. (2022). Cardiac resident macrophage-derived legumain improves cardiac repair by promoting clearance and degradation of apoptotic cardiomyocytes after myocardial infarction. Circulation, 145(20), 1542-1556.

Reddy, B. D., Beeraka, N. M., Chitturi, C. H., & Madhunapantula, S. V. (2021). An overview of targeting legumain for inhibiting cancers. Current Pharmaceutical Design, 27(31), 3337-3348.

Wang, H., Chen, B., Lin, Y., Zhou, Y., & Li, X. (2020). Legumain promotes gastric cancer progression through tumor-associated macrophages in vitro and in vivo. International Journal of Biological Sciences, 16(1), 172.

Ren, Y. C., Zhao, Q., He, Y., Li, B., Wu, Z., Dai, J., ... & Hu, G. (2020). Legumain promotes fibrogenesis in chronic pancreatitis via activation of transforming growth factor β1. Journal of Molecular Medicine, 98, 863-874.

Wang, Y., Zhang, S., Wang, H., Cui, Y., Wang, Z., Cheng, X., ... & Liu, T. (2020). High level of legumain was correlated with worse prognosis and peritoneal metastasis in gastric cancer patients. Frontiers in Oncology, 10, 966.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols

Related Products

Mouse Anti-LGMN Recombinant Antibody (CBYJL-1544)

Mouse Anti-LGMN Recombinant Antibody (46I3)

Rabbit Anti-LGMN Recombinant Antibody (D6S4H)

Mouse Anti-LGMN Recombinant Antibody (CBYC-A995)

Mouse Anti-LGMN Recombinant Antibody (M2)

Mouse Anti-LGMN Recombinant Antibody (M1)

Mouse Anti-LGMN Recombinant Antibody (CBYJL-1540)

Isotype control